The first CryoValve SG pulmonary human heart valve, manufactured by CryoLife, has been received by the first patient. The product was approved by the FDA in February and is used in replacing the malfunctioning native pulmonary valves in patients. Children with congenital heart defects can also receive the valve for right ventricular outflow tract reconstruction procedures.